Tau proteins and MAPT — shaping neural stability
A body of studies is showing that a blood marker called p-tau217 can forecast an elevated risk of cognitive impairment in healthy older adults years before symptoms appear. The evidence is not yet clinical-ready, but it is guiding trials that aim to slow or prevent Alzheimer’s disease and is being tested in Scotland’s primary care setting.
International researchers find inherited genetics influence how cancers evolve after DNA damage, affecting tumour growth and mutation patterns. The Edinburgh-led work, published in Nature, underlines implications for screening, diagnosis and personalised treatment across populations.